Person · CIK 1780088

Barry Ticho

CHIEF MEDICAL OFFICER at Stoke Therapeutics

Earlier: Verve Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$6.9M

Noticed on Form 144$3.8M

Bought on Form 4$0

Companies2

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Stoke Therapeutics STOK	Common Stock	Directly	19,059	Oct 1, 2026 · Filing · EDGAR
Verve Therapeutics	Common Stock	Directly	409,626	Jun 16, 2021 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q4 2026	$27K	—
Q3 2026	$767K	$842K
Q2 2026	$188K	$192K
Q1 2026	$457K	$45K
Q4 2025	$567K	$240K
Q3 2025	$271K	$317K
Q2 2025	$349K	$340K
Q1 2025	$61K	—
Q4 2024	$580K	$247K
Q3 2024	$433K	$449K
Q2 2024	$391K	$458K
Q1 2024	$208K	$178K
Q3 2023	$159K	—
Q2 2023	$729K	$443K
Q1 2023	$192K	Not machine-readable
Q3 2021	$1.4M	Not machine-readable
Q4 2020	$79K	Not machine-readable
Q2 2020	$37K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Nov 19, 2025 · 5 notices
Aug 3, 2026	20,967 · ~$605K	Aug 3, 2026	Partly sold Sold 18,539 in 7 sales, Aug 3 to Oct 1 · $559K likely match Form 4 (1) · Form 4 (2) · Form 4 (3) · Form 4 (4)	Filing · EDGAR
Jul 1, 2026	7,228 · ~$237K	Jul 1, 2026	Sold as noticed Sold 7,228 in 2 sales, Jul 1 to Jul 1 · $236K Form 4	Filing · EDGAR
May 1, 2026	4,038 · ~$132K	May 1, 2026	Sold as noticed Sold 4,038 in 2 sales, May 1 to Jun 1 · $128K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Apr 1, 2026	1,838 · ~$60K	Apr 1, 2026	Sold as noticed Sold 1,838 at $32.66 on Apr 1 · $60K Form 4	Filing · EDGAR
Mar 19, 2026	1,461 · ~$45K	Mar 19, 2026	Partly sold Sold 586 in 2 sales, Mar 18 to Mar 18 · $19K likely match Form 4	Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 11, 2024 · 5 notices
Dec 5, 2025	1,989 · ~$62K	Dec 5, 2025	Sold as noticed Sold 2,006 in 2 sales, Dec 2 to Dec 2 · $60K Form 4	Filing · EDGAR
Nov 3, 2025	5,931 · ~$178K	Nov 3, 2025	Partly sold Sold 5,831 in 3 sales, Nov 3 to Nov 3 · $150K likely match Form 4	Filing · EDGAR
Sep 2, 2025	10,844 · ~$214K	Sep 2, 2025	Sold as noticed Sold 10,944 in 3 sales, Sep 2 to Nov 3 · $239K Form 4 (1) · Form 4 (2) · Form 4 (3)	Filing · EDGAR
Jul 1, 2025	9,007 · ~$102K	Jul 1, 2025	Sold as noticed Sold 9,007 in 2 sales, Jul 1 to Aug 1 · $110K Form 4 (1) · Form 4 (2)	Filing · EDGAR
May 1, 2025	34,847 · ~$340K	May 1, 2025	Sold as noticed Sold 34,847 in 4 sales, May 1 to Jun 3 · $349K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 14, 2023 · 7 notices
Nov 1, 2024	20,000 · ~$247K	Nov 1, 2024	Sold as noticed Sold 20,000 in 2 sales, Nov 1 to Dec 2 · $248K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Aug 1, 2024	30,000 · ~$449K	Aug 1, 2024	Sold as noticed Sold 30,000 in 4 sales, Aug 1 to Oct 1 · $416K Form 4 (1) · Form 4 (2) · Form 4 (3)	Filing · EDGAR
May 1, 2024	30,000 · ~$331K	May 1, 2024	Sold as noticed Sold 30,000 in 4 sales, May 1 to Jul 1 · $403K Form 4 (1) · Form 4 (2) · Form 4 (3)	Filing · EDGAR
Apr 1, 2024	9,426 · ~$127K	Apr 1, 2024	Sold as noticed Sold 9,426 at $13.23 on Apr 1 · $125K Form 4	Filing · EDGAR
Mar 1, 2024	10,000 · ~$77K	Mar 1, 2024	Sold as noticed Sold 10,000 at $7.75 on Mar 1 · $77K Form 4	Filing · EDGAR
Feb 1, 2024	10,000 · ~$48K	Feb 1, 2024	Sold as noticed Sold 10,000 at $4.80 on Feb 1 · $48K Form 4	Filing · EDGAR
Jan 2, 2024	10,000 · ~$53K	Jan 2, 2024	Sold as noticed Sold 10,000 at $5.74 on Jan 2 · $57K Form 4	Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Nov 17, 2022 · 1 notice
May 3, 2023	45,000 · ~$443K	May 3, 2023	Partly sold Sold 31,133 in 3 sales, May 1 to May 4 · $311K likely match Form 4 (1) · Form 4 (2)	Filing · EDGAR
Sales without a matching Form 144 · 31 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,461 at $29.99 on Mar 19, 2026 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 6,100 at $31.28 on Mar 18, 2026 · $191K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 2,587 at $33.38 on Mar 17, 2026 · $86K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 3,577 at $32.74 on Mar 17, 2026 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,989 at $31.35 on Dec 5, 2025 · $62K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,673 at $31.33 on Dec 5, 2025 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 323 at $31.32 on Dec 4, 2025 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,373 at $30.76 on Dec 4, 2025 · $42K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,225 at $30.85 on Dec 3, 2025 · $38K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 789 at $30.34 on Dec 3, 2025 · $24K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 2,805 at $18.24 on Aug 18, 2025 · $51K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 3,333 at $8.27 on Mar 19, 2025 · $28K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 3,884 at $8.67 on Mar 18, 2025 · $34K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 2,586 at $12.99 on Dec 9, 2024 · $34K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 13,945 at $12.78 on Dec 6, 2024 · $178K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 4,116 at $6.10 on Mar 19, 2024 · $25K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 15,000 at $10.60 on Jul 3, 2023 · $159K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 15,000 at $11.13 on Jun 1, 2023 · $167K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 24,697 at $10.14 on May 3, 2023 · $250K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 9,235 at $10.02 on Feb 6, 2023 · $92K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 3,763 at $10.03 on Feb 3, 2023 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 267 at $10.00 on Feb 2, 2023 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 5,705 at $10.02 on Feb 1, 2023 · $57K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 200 at $10.00 on Jan 31, 2023 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 3,300 at $33.55 on Jul 13, 2021 · $111K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 39,866 at $32.68 on Jul 13, 2021 · $1.3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 365 at $59.00 on Dec 21, 2020 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 286 at $58.02 on Dec 21, 2020 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 714 at $56.76 on Dec 21, 2020 · $41K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 365 at $27.98 on Jun 1, 2020 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 1,000 at $27.17 on Jun 1, 2020 · $27K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Stoke Therapeutics STOK Chief medical officer · filings 2019 to 2026 · sold $6.9M · $3.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 1, 2026	Sale under a 10b5-1 plan	−1,051	$26.16	$27K	19,059 direct	Filing · EDGAR
Sep 1, 2026	Sale under a 10b5-1 plan	−3,945	$30.51	$120K	21,710 direct	Filing · EDGAR
Sep 1, 2026	Sale under a 10b5-1 plan	−1,600	$31.06	$50K	20,110 direct	Filing · EDGAR
Aug 18, 2026	Open-market or private sale	−4,525	$32.01	$145K	25,897 direct	Filing · EDGAR
Aug 18, 2026	Open-market or private sale	−242	$32.47	$8K	25,655 direct	Filing · EDGAR
Aug 14, 2026	Option or RSU exercised or converted	+10,000			30,422 direct	Filing · EDGAR
Aug 14, 2026	Option or RSU exercised or converted Performance Stock Units	−10,000			0 direct	Filing · EDGAR
Aug 3, 2026	Sale under a 10b5-1 plan	−5,907	$28.95	$171K	21,691 direct	Filing · EDGAR
Aug 3, 2026	Sale under a 10b5-1 plan	−1,269	$29.45	$37K	20,422 direct	Filing · EDGAR
Jul 1, 2026	Sale under a 10b5-1 plan	−6,728	$32.62	$219K	28,098 direct	Filing · EDGAR
Jul 1, 2026	Sale under a 10b5-1 plan	−500	$33.27	$17K	27,598 direct	Filing · EDGAR
Jun 1, 2026	Sale under a 10b5-1 plan	−1,795	$30.58	$55K	34,826 direct	Filing · EDGAR
May 1, 2026	Sale under a 10b5-1 plan	−2,243	$32.79	$74K	36,621 direct	Filing · EDGAR
Apr 1, 2026	Sale under a 10b5-1 plan	−1,838	$32.66	$60K	38,864 direct	Filing · EDGAR
Mar 19, 2026	Option or RSU exercised or converted	+1,365	$2.19	$3K	42,163 direct	Filing · EDGAR
Mar 19, 2026	Sale under a 10b5-1 plan	−1,461	$29.99	$44K	40,702 direct	Filing · EDGAR
Mar 19, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−1,365			83,035 direct	Filing · EDGAR
Mar 18, 2026	Sale under a 10b5-1 plan	−6,100	$31.28	$191K	41,384 direct	Filing · EDGAR
Mar 18, 2026	Sale under a 10b5-1 plan	−483	$31.79	$15K	40,901 direct	Filing · EDGAR
Mar 18, 2026	Sale under a 10b5-1 plan	−103	$32.85	$3K	40,798 direct	Filing · EDGAR
Mar 17, 2026	Sale under a 10b5-1 plan	−3,577	$32.74	$117K	50,071 direct	Filing · EDGAR
Mar 17, 2026	Sale under a 10b5-1 plan	−2,587	$33.38	$86K	47,484 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted	+13,100			32,898 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted	+10,000			42,898 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted	+10,750			53,648 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted Restricted Stock Units	−13,100			13,100 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted Restricted Stock Units	−10,000			20,000 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted Restricted Stock Units	−10,750			32,250 direct	Filing · EDGAR
Feb 17, 2026	Grant or award from the company Employee Stock Option (Right to Buy)	+60,000			60,000 direct	Filing · EDGAR
Feb 17, 2026	Grant or award from the company Restricted Stock Units	+40,000			40,000 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−1,673	$31.33	$52K	21,787 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−1,989	$31.35	$62K	19,798 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−1,373	$30.76	$42K	23,783 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−323	$31.32	$10K	23,460 direct	Filing · EDGAR
Dec 3, 2025	Option or RSU exercised or converted	+10,000			25,156 direct	Filing · EDGAR
Dec 3, 2025	Option or RSU exercised or converted Performance Stock Units	−10,000			0 direct	Filing · EDGAR
Dec 3, 2025	Open-market or private sale	−789	$30.34	$24K	16,381 direct	Filing · EDGAR
Dec 3, 2025	Open-market or private sale	−1,225	$30.85	$38K	15,156 direct	Filing · EDGAR
Dec 2, 2025	Open-market or private sale	−1,244	$29.56	$37K	17,932 direct	Filing · EDGAR
Dec 2, 2025	Open-market or private sale	−762	$30.14	$23K	17,170 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted	+11,981			19,176 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−11,981			0 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−3,776	$25.22	$95K	9,350 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−1,455	$26.02	$38K	7,895 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−600	$27.54	$17K	7,295 direct	Filing · EDGAR
Nov 3, 2025	Sale under a 10b5-1 plan	−100	$29.35	$3K	7,195 direct	Filing · EDGAR
Oct 1, 2025	Sale under a 10b5-1 plan	−5,343	$23.64	$126K	13,126 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−5,501	$19.87	$109K	18,469 direct	Filing · EDGAR
Aug 18, 2025	Open-market or private sale	−2,805	$18.24	$51K	23,970 direct	Filing · EDGAR
Aug 14, 2025	Option or RSU exercised or converted	+10,000			26,775 direct	Filing · EDGAR
Aug 14, 2025	Grant or award from the company Performance Stock Units	+20,000			20,000 direct	Filing · EDGAR
Aug 14, 2025	Option or RSU exercised or converted Performance Stock Units	−10,000			10,000 direct	Filing · EDGAR
Aug 1, 2025	Sale under a 10b5-1 plan	−4,504	$12.82	$58K	16,775 direct	Filing · EDGAR
Jul 1, 2025	Sale under a 10b5-1 plan	−4,503	$11.63	$52K	21,279 direct	Filing · EDGAR
Jun 3, 2025	Sale under a 10b5-1 plan	−6,471	$10.03	$65K	25,782 direct	Filing · EDGAR
Jun 2, 2025	Sale under a 10b5-1 plan	−1,745	$10.00	$17K	32,253 direct	Filing · EDGAR
May 2, 2025	Sale under a 10b5-1 plan	−22,790	$10.03	$229K	33,998 direct	Filing · EDGAR
May 1, 2025	Sale under a 10b5-1 plan	−3,841	$10.00	$38K	56,788 direct	Filing · EDGAR
Mar 20, 2025	Grant or award from the company Employee Stock Option (Right to Buy)	+64,000			64,000 direct	Filing · EDGAR
Mar 20, 2025	Grant or award from the company Restricted Stock Units	+43,000			43,000 direct	Filing · EDGAR

86 earlier transactions are in the filing list below.

Verve Therapeutics 10% owner · filings 2021 to 2021

No transactions in the filings read; Form 144 notices are listed above.

All 76 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 2, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 3, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 18, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 5, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 3, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Jul 6, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 1, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Jun 3, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 5, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 1, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Apr 3, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Apr 1, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Mar 19, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Mar 19, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 17, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 19, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 3, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 3, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Oct 3, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 3, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 2, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Aug 20, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 18, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 2, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 1, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Jun 4, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 1, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Mar 20, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 18, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 11, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 10, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 3, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Oct 2, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Jul 3, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 7, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 3, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Apr 3, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Apr 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Mar 19, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Feb 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 1, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Jan 4, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 2, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 6, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 5, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 8, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 3, 2023	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
May 3, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 17, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 7, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 2, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 9, 2022	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 17, 2022	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 15, 2021	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 16, 2021	Form 3	Verve Therapeutics	Filing · EDGAR
Mar 4, 2021	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 21, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 3, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 26, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 18, 2019	Form 3	Stoke Therapeutics STOK	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 4:30 PM ET. The filing on SEC.gov is the record.